Application
Figure 1: Western blot analysis using PEG10 mouse mAb against HepG2 (1), SMMC-7721 (2) and A549 (3) cell lysate.Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human hepatocarcinoma (A), breast carcinoma (B) and lung cancer tissues (C), showing cytoplasmic localization with DAB staining using PEG10 mouse mAb.Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human Placenta tissues using PEG10 mouse mAb| Product Name | PEG10 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | Edr; HB-1; Mar2; MEF3L; Mart2; RGAG3 |
| Immunogen | Purified recombinant fragment of human PEG10 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | Edr HB-1 Mar2 MEF3L Mart2 RGAG3 |
|---|---|
| Molecular Weight(MW) | Isoform RF1 (37kDa); RF1/RF2 (80kDa) |
| Entrez Gene | 23089 |
|---|
Application
Figure 1: Western blot analysis using PEG10 mouse mAb against HepG2 (1), SMMC-7721 (2) and A549 (3) cell lysate.
Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human hepatocarcinoma (A), breast carcinoma (B) and lung cancer tissues (C), showing cytoplasmic localization with DAB staining using PEG10 mouse mAb.
Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human Placenta tissues using PEG10 mouse mAb| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
